SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs Tempus ECG-Low EF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by DIACOUSTIC MEDICAL DEVICES (PTY)
VS
by Tempus

AI Verdict

These tools are adjacent in the cardiology AI space, both providing clinical decision support. SensiCardiac Mobi assists in diagnosing heart murmurs by analyzing acoustic signals from a stethoscope, while Tempus ECG-Low EF analyzes 12-lead ECGs to detect signs of low left ventricular ejection fraction. A clinician would choose between them based on whether they need to evaluate heart sounds for murmurs or screen for heart failure risk via ECG.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SENSICARDIAC MOBI if you need an AI-powered mobile solution for real-time auscultation and immediate differentiation of heart murmurs at the point of care. This tool is ideal for physicians who use an electronic stethoscope and require assistance in distinguishing between physiological and pathological heart sounds during patient examinations.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose Tempus ECG-Low EF if…

Choose Tempus ECG-Low EF if your primary goal is to screen patients aged 40 or older for signs of low left ventricular ejection fraction (LVEF ≤40%) using standard 12-lead ECG recordings. This software is best suited for integrating into existing healthcare facility workflows to identify patients at risk of heart failure who may require further cardiac evaluation.

View Tempus ECG-Low EF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION Tempus ECG-Low EF
Pricing Contact for pricing Unknown
Deployment Hosted server environment (Linux OS) with a mobile application interface Integrates with current ECG platforms and electronic health records (EHRs).
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Tool A, with its mobile application interface for data capture and display, suggests a direct and potentially intuitive user experience at the point of care. While it requires a compatible stethoscope, the app itself is designed for immediate physician interaction. Tool B's integration into facility workflows, while efficient, may offer less direct user control over the analysis process.

Clinical Value

Tempus ECG-Low EF

Tool B addresses the critical issue of identifying patients at risk for low LVEF and subsequent heart failure, a condition with high morbidity and mortality, potentially enabling earlier intervention and broader population health impact. Its training on a large dataset of over 930,000 ECGs also suggests robust clinical backing. While Tool A provides direct diagnostic assistance for murmurs, Tool B targets a condition with higher morbidity and mortality.

Pricing & Value

Tie

Both tools have opaque pricing models, requiring direct contact with the vendor. Without publicly available pricing information, it is impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value proposition.

Enterprise Readiness

Tempus ECG-Low EF

Tool B's deployment model, described as 'Software, integrated into healthcare facility workflows,' suggests a more seamless adoption into existing IT infrastructure and clinical processes, which is crucial for large-scale enterprise readiness. Tool A's reliance on a user-provided electronic stethoscope could introduce complexities in procurement, standardization, and large-scale deployment within an enterprise setting.

Innovation

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Tool A demonstrates a highly innovative approach by integrating AI with a mobile application and electronic stethoscope to analyze acoustic heart signals for real-time murmur differentiation, directly augmenting a traditional physical examination. While Tool B's application of AI to ECGs for LVEF prediction is valuable, the method of AI-driven ECG analysis is becoming a more established area.

Support & Docs

Tie

The provided structured facts do not include any information regarding support and documentation for either tool. Furthermore, public web searches do not readily provide distinguishing details to compare them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION Tempus ECG-Low EF
Name SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION Tempus ECG-Low EF
Company DIACOUSTIC MEDICAL DEVICES (PTY) Tempus AI
Primary Diagnostic Focus Assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals to differentiate between physiological and pathological sounds Detects signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure
Input Data Type Acoustic heart signals from an electronic stethoscope Resting, non-ambulatory 12-lead ECG recordings
Output Distinguishes between normal/physiological and pathological heart murmurs; Identifies S1, S2, and suspected murmurs; Operates as a decision support software Binary output (Low LVEF Detected / Not Detected)
Required External Devices Compatible electronic stethoscope (user-provided); Mobile application for data capture and display (e.g., iPhone 4S or later) Not specified

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and Tempus ECG-Low EF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

SensiCardiac Mobi operates as a mobile application for data capture and display, requiring a compatible electronic stethoscope for acoustic heart signal acquisition. Tempus ECG-Low EF is designed to be integrated into healthcare facility workflows, analyzing existing 12-lead ECG recordings.
SensiCardiac Mobi assists in diagnosing heart murmurs by differentiating between physiological and pathological sounds, suitable for Cardiology, Internal Medicine, and Pediatrics. Tempus ECG-Low EF detects signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure, aiding clinicians in further evaluation.
SensiCardiac Mobi requires a physician to actively acquire and record acoustic heart signals using a user-provided electronic stethoscope via its mobile application. Tempus ECG-Low EF analyzes resting, non-ambulatory 12-lead ECG recordings, which are typically already part of standard clinical diagnostic settings.
For SensiCardiac Mobi, physicians would need to become proficient with the mobile application interface and the technique for recording heart sounds at four main auscultation positions. Tempus ECG-Low EF, by analyzing existing ECGs within facility workflows, likely presents a minimal learning curve for physicians in its direct use.
SensiCardiac Mobi analyzes heart sounds using the proprietary Sensi Diagnostic Heart Murmur Algorithm. Tempus ECG-Low EF's AI algorithm was trained on a large dataset of over 930,000 ECGs from more than 170,000 patients.
The provided information does not explicitly detail specific audit trail features for either SensiCardiac Mobi or Tempus ECG-Low EF beyond their operational descriptions.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.